BANDAR SERI BEGAWAN
Tuesday, February 3, 2015
BRUNEI’S first pharmaceutical manufacturing plant is eyeing to export medicines and health supplements to ASEAN countries within the year.
According to Gerhard Schieber, plant manager for Simpor Pharma, the company is processing the registration of its pharmaceutical and health supplement products in different countries. Once the registration process is completed, the company can sell its products across Southeast Asia.
Schieber said the company is using very little amount of the total capacity of the plant. He expects that once the registration process is completed, operations will be in full swing.
“The installation is ready, the facility is ready,” he said, noting the company’s production capacity is “very high”.
He cited that one machine alone can produce three million soft gelatin capsules and that the plant is capable of manufacturing as much as 15 million capsules per day.
He said Simpor Pharma has two tablet presses that can produce five million tablets per eight hour shift for each machine. The plant can also manufacture large amount of powders and granules.
Schieber said Simpor Pharma is also planning to produce hard-shell capsules and film coated tablets.
Simpor Pharma was established to produce Syariah-compliant pharmaceutical products for export to Muslim markets in Asia. The company is a $26 million joint-venture among Canadian Firm Viva Pharmaceutical Inc, private equity fund Aureous (Brunei) Capital Sdn Bhd and a group of local investors.
In a previous report, an official from Simpor Pharma said that the plant was established by Viva Canada as a base for expanding its product range into Muslim countries, and had selected Brunei due to its political stability.
Courtesy of The Brunei Times